4//SEC Filing
VAN LUNSEN GIL J 4
Accession 0001562180-18-003682
CIK 0001100412other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:46 PM ET
Size
13.3 KB
Accession
0001562180-18-003682
Insider Transaction Report
Form 4
VAN LUNSEN GIL J
Director
Transactions
- Exercise/Conversion
Common Stock
2018-08-15$5.60/sh+14,500$81,200→ 40,797 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-08-15−7,000→ 18,000 totalExercise: $5.95Exp: 2026-10-27→ Common Stock (7,000 underlying) - Exercise/Conversion
Common Stock
2018-08-15$5.95/sh+7,000$41,650→ 26,297 total - Sale
Common Stock
2018-08-15$13.92/sh−21,500$299,280→ 19,297 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-08-15−14,500→ 0 totalExercise: $5.60Exp: 2023-10-23→ Common Stock (14,500 underlying)
Footnotes (3)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]Options vested on October 27, 2017.
- [F3]Options vested on October 23, 2014.
Issuer
ARRAY BIOPHARMA INC
CIK 0001100412
Entity typeother
Related Parties
1- filerCIK 0001205014
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:46 PM ET
- Size
- 13.3 KB